03:35 PM EDT, 05/27/2026 (MT Newswires) -- Healthcare stocks rose late Wednesday afternoon with the NYSE Healthcare Index gaining 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.3%.

The iShares Biotechnology ETF (IBB) added 0.5%.

In corporate news, BioNTech's (BNTX) cancer-drug pipeline is showing stronger early results and is approaching several important clinical milestones, improving confidence in the company's long-term outlook, UBS Securities said. BioNTech shares rose 1.4%.

Corcept Therapeutics ( CORT ) shares jumped 9.7% after the company said it will resubmit its new drug application to the US Food and Drug Administration in the coming weeks for relacorilant to treat Cushing's syndrome.

Boston Scientific ( BSX ) shares slumped 12% after CEO Mike Mahoney said this year has been "a bit more of a challenge" than anticipated.

Guardant Health ( GH ) shares gained 5.6% after the company said its Shield blood test has been included in the American Cancer Society's updated Colorectal Cancer Screening guidelines.